Zhejiang Huahai Pharmaceutical Co Ltd Net Asset Quality Index

Latest as of June 2026: 45.8%

Zhejiang Huahai Pharmaceutical Co Ltd net asset quality index. Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Net Asset Quality Index of 45.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥21.95 Billion minus total liabilities of CN¥11.90 Billion yields net assets of CN¥10.04 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Zhejiang Huahai Pharmaceutical Co Ltd (600521) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Quality Index

45.8%
Equity / Total Assets

Net Assets

CN¥10.04 Billion
CNY

Total Assets

CN¥21.95 Billion
CNY

Total Liabilities

CN¥11.90 Billion
CNY

Net Asset Quality Index of Zhejiang Huahai Pharmaceutical Co Ltd (2000–2025)

Net asset quality index of Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2025. This chart shows how Zhejiang Huahai Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the index stands at 45.8%, representing net assets of CN¥10.04 Billion against total assets of CN¥21.95 Billion CNY. See Zhejiang Huahai Pharmaceutical Co Ltd (600521) net assets for net asset value and shareholders' equity analysis.

Zhejiang Huahai Pharmaceutical Co Ltd Net Asset Quality Index by Year (2000–2025)

Zhejiang Huahai Pharmaceutical Co Ltd net asset quality index by year from 2000 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Zhejiang Huahai Pharmaceutical Co Ltd market capitalisation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 44.0% CN¥9.46 Billion CN¥21.50 Billion CN¥12.05 Billion ▼ -0.5 pp
2024 44.5% CN¥9.02 Billion CN¥20.26 Billion CN¥11.24 Billion ▲ +0.2 pp
2023 44.4% CN¥8.25 Billion CN¥18.60 Billion CN¥10.35 Billion ▲ +1.7 pp
2022 42.7% CN¥7.75 Billion CN¥18.15 Billion CN¥10.41 Billion ▼ -1.1 pp
2021 43.8% CN¥6.78 Billion CN¥15.47 Billion CN¥8.69 Billion ▼ -8.0 pp
2020 51.8% CN¥6.72 Billion CN¥12.99 Billion CN¥6.27 Billion ▼ -2.1 pp
2019 53.9% CN¥5.78 Billion CN¥10.73 Billion CN¥4.95 Billion ▲ +13.3 pp
2018 40.6% CN¥4.21 Billion CN¥10.37 Billion CN¥6.16 Billion ▼ -20.6 pp
2017 61.1% CN¥5.05 Billion CN¥8.27 Billion CN¥3.21 Billion ▼ -6.9 pp
2016 68.1% CN¥4.58 Billion CN¥6.73 Billion CN¥2.15 Billion ▲ +0.6 pp
2015 67.5% CN¥3.72 Billion CN¥5.52 Billion CN¥1.80 Billion ▼ -5.0 pp
2014 72.4% CN¥3.27 Billion CN¥4.51 Billion CN¥1.24 Billion ▲ +4.8 pp
2013 67.6% CN¥3.02 Billion CN¥4.47 Billion CN¥1.45 Billion ▲ +7.0 pp
2012 60.6% CN¥1.95 Billion CN¥3.22 Billion CN¥1.27 Billion ▲ +1.2 pp
2011 59.4% CN¥1.53 Billion CN¥2.58 Billion CN¥1.05 Billion ▼ -4.8 pp
2010 64.2% CN¥1.32 Billion CN¥2.05 Billion CN¥735.92 Million ▼ -5.7 pp
2009 69.9% CN¥1.21 Billion CN¥1.74 Billion CN¥522.98 Million ▼ -2.8 pp
2008 72.7% CN¥1.10 Billion CN¥1.52 Billion CN¥414.51 Million ▼ -4.5 pp
2007 77.2% CN¥975.52 Million CN¥1.26 Billion CN¥287.78 Million ▼ -2.5 pp
2006 79.7% CN¥875.40 Million CN¥1.10 Billion CN¥222.66 Million ▼ -2.6 pp
2005 82.3% CN¥802.34 Million CN¥975.04 Million CN¥172.70 Million ▼ -5.4 pp
2004 87.7% CN¥785.53 Million CN¥895.55 Million CN¥110.03 Million ▼ -0.8 pp
2003 88.5% CN¥685.42 Million CN¥774.68 Million CN¥89.27 Million ▲ +56.0 pp
2002 32.5% CN¥80.56 Million CN¥248.18 Million CN¥167.62 Million ▲ +0.2 pp
2001 32.2% CN¥72.15 Million CN¥223.88 Million CN¥151.72 Million ▼ -4.4 pp
2000 36.6% CN¥65.23 Million CN¥178.02 Million CN¥112.79 Million —
pp = percentage points